{"id":"NCT00671502","sponsor":"Meda Pharmaceuticals","briefTitle":"A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back","officialTitle":"Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2008-05-05","resultsPosted":"2011-11-09","lastUpdate":"2011-11-09"},"enrollment":840,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lower Back Pain"],"interventions":[{"type":"DRUG","name":"Carisoprodol SR","otherNames":["sustained release(SR)"]},{"type":"DRUG","name":"Carisoprodol SR","otherNames":["sustained release(SR) tablet"]},{"type":"DRUG","name":"Placebo","otherNames":["no other name"]}],"arms":[{"label":"Carisoprodol 700mg","type":"EXPERIMENTAL"},{"label":"Carisoprodol 500mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.","primaryOutcome":{"measure":"Subject Rating of Pain on a 100-point Visual Analog Scale (VAS)","timeFrame":"up to 14 days","effectByArm":[{"arm":"Carisoprodol 500mg Tablets","deltaMin":27.5,"sd":null},{"arm":"Carisoprodol 700mg Tablets","deltaMin":28,"sd":null},{"arm":"Placebo Tablets","deltaMin":28.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":68,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":278},"commonTop":["somnolence","dizziness","nausea","headache","fatigue"]}}